Skip to main content
2026 CRT Conference Main banner

Charles A. Simonton, MD, FACC, FSCAI

EVP Chief Medical Advisor
Abiomed a Johnson + Johnson MedTech Company
Charlotte, North Carolina, United States

Charles Simonton MD is Chief Medical Advisor, Abiomed J+J Heart Recovery. He joined Abiomed in June 2020 as Chief Medical Officer for Global Medical and Clinical Affairs. He is renowned for his leadership in product development and large-scale clinical trials. From 2008-2019 he was at Abbott Vascular where he served as Chief Medical Officer for Global Medical and Clinical Affairs. He led the programs that resulted in U.S. FDA's approval of carotid stents, MitraClip™ and Absorb BVS, in addition to the EXCEL and COAPT trials. Prior to Abbott, he spent 25 years as an interventional cardiologist working with complex cardiac and vascular patients at Duke University Medical Center and the Sanger Clinic, Charlotte NC. He received his medical degree from Harvard Medical School and did internal medicine residency and chief residency at the University of California SF and his cardiology fellowship at Duke University.

Disclosure(s): Abiomed / Johnson & Johnson: Employee (Ongoing)

Presentation(s):